Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 4 2Phase NA 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 1Smoking 1Lung Neoplasms 1

Interventions

pembrolizumab 8Nivolumab 7Magnetic Resonance Spectroscopy 7Radiotherapy 6Biopsy 4Temozolomide 3Specimen Handling 3Irinotecan 3Ipilimumab 3Fluorodeoxyglucose F18 3Dexamethasone 3Bevacizumab 3venetoclax 2niraparib 2gallium 68 PSMA-11 2durvalumab 2avelumab 2Tobacco Use Cessation Devices 2Standard of Care 2Rituximab 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Neoadjuvant Therapy 2Metastasectomy 2Immunoglobulin G 2FAPI-46 2Disulfides 2Cyclophosphamide 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Tobacco Use Cessation Devices × Clear all
NCT03059940 2026-04-15

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
630 enrolled

Smoking Cessation

NCT04200534 2025-08-22

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
358 enrolled
Thoracic

Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡